Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K1BV
|
||||
Former ID |
DNC010085
|
||||
Drug Name |
N-(17-Methylmorphinan-3-yl)-N'-phenylurea
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530529] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H29N3O
|
||||
Canonical SMILES |
CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)NC(=O)NC5=CC=CC=C5
|
||||
InChI |
1S/C24H29N3O/c1-27-14-13-24-12-6-5-9-20(24)22(27)15-17-10-11-19(16-21(17)24)26-23(28)25-18-7-3-2-4-8-18/h2-4,7-8,10-11,16,20,22H,5-6,9,12-15H2,1H3,(H2,25,26,28)/t20-,22+,24+/m0/s1
|
||||
InChIKey |
CVZRQQXQPKBKNJ-BGWNEDDSSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [530529] | |
Delta-type opioid receptor | Target Info | Inhibitor | [530529] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [530529] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.